Korula, Anu ; A, Fouzia N ; Devasia, Anup ; Kulkarni, Uday ; Abraham, Aby ; George, Biju ; Srivastava, Alok ; Mathews, Vikram (2020) HL-215: Short-Course Nivolumab as a Bridge to Stem Cell Transplant is Effective in Refractory Hodgkin Lymphoma Clinical Lymphoma Myeloma and Leukemia, 20 . S247. ISSN 2152-2650
Full text not available from this repository.
Official URL: http://doi.org/10.1016/S2152-2650(20)30839-9
Related URL: http://dx.doi.org/10.1016/S2152-2650(20)30839-9
Abstract
Context Immune checkpoint inhibitors are effective in the setting of HL with relapse after autologous transplant, in disease refractory to Brentuximab, and upfront in advanced stage disease. PD-1 blockade is an expensive treatment option; therefore, truncated dosing schedules are relevant.
| Item Type: | Article |
|---|---|
| Source: | Copyright of this article belongs to Elsevier Science. |
| ID Code: | 124093 |
| Deposited On: | 03 Nov 2021 10:33 |
| Last Modified: | 03 Nov 2021 10:33 |
Repository Staff Only: item control page
